Transaminitis in a Three-year-old Boy with Duchenne Muscular Dystrophy
Open Access
- 10 October 2020
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 8 (4), 1-2
- https://doi.org/10.14218/jcth.2020.00038
Abstract
Duchenne muscular dystrophy (DMD) is a fatal X-linked genetic disease of the neuromuscular system and is the most serious type of muscular dystrophy in humans. The disease is characterized by progressive muscular atrophy and a poor prognosis. The incidence rate is 1/3500, and symptoms appear at age of 5 years-old. Some patients present with abnormal aminotransferases as the first symptom. In addition to the clinical characteristics and genetic history, electromyography examination, muscle biopsy, serum enzyme examination, and measures of creatine kinase (CK), CK isoenzyme, and serum lactate dehydrogenase are important features of auxiliary examination. Clinicians who encounter unknown causes of transaminitis should consider the possibility of DMD. We describe here a 3 year-old pediatric patient with increased aminotransferases who had elevated CK and a family genetic history but without liver damage on computed tomography. He was suspected as having inherited the disorder and was finally diagnosed as having DMD by next-generation sequencing.Keywords
This publication has 13 references indexed in Scilit:
- Muscular dystrophiesThe Lancet, 2019
- Stem cell-based therapies for Duchenne muscular dystrophyExperimental Neurology, 2019
- Therapeutic developments for Duchenne muscular dystrophyNature Reviews Neurology, 2019
- Stem Cells in the Treatment of DiseaseThe New England Journal of Medicine, 2019
- Creatine kinase myocardial band - a biomarker to assess prognostically relevant periprocedural myocardial infarctionInternational Journal of Cardiology, 2018
- Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophyMolecular Therapy, 2018
- Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutationGene, 2018
- The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence reviewOrphanet Journal of Rare Diseases, 2017
- Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutationsJournal of Human Genetics, 2016
- The importance of genetic diagnosis for Duchenne muscular dystrophyJournal of Medical Genetics, 2016